Dormio Tech’s innovative FloChannel is said to be the only diagnostic device that independently monitors left and right nasal airflow.
This allows the system to detect and measure nasal cycling (the periodic alternation in nasal airflow resistance between the two nasal cavities), as well as oral airflow and snoring, and provides constant baseline airflow volumetric sleep scoring. The patented device connects easily to standard sleep lab systems.
Earl Yager, president and CEO of Chad Therapeutics, said: “With its patented features and unique capabilities, we believe FloChannel is a significant advance in the diagnosis of obstructive sleep apnea and other sleep disorders, and may become an invaluable tool in attended sleep laboratories.”